Cargando…
Personalized Medicine of Alzheimer’s Disease
Alzheimer’s disease (AD) is a major problem of health and disability, with a relevant economic impact on society (e.g., €177 billion in Europe). Despite important advances in pathogenesis, diagnosis, and treatment, The primary causes of AD remain elusive, accurate biomarkers are not well characteriz...
Autores principales: | Cacabelos, Ramón, Cacabelos, Pablo, Torrellas, Clara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149555/ http://dx.doi.org/10.1016/B978-0-12-386882-4.00027-X |
Ejemplares similares
-
Epigenetics of Aging and Alzheimer’s Disease: Implications for Pharmacogenomics and Drug Response
por: Cacabelos, Ramón, et al.
Publicado: (2015) -
Optimization of Antidepressant use with Pharmacogenetic Strategies
por: Torrellas, Clara, et al.
Publicado: (2017) -
Personalized Management and Treatment of Alzheimer’s Disease
por: Cacabelos, Ramón, et al.
Publicado: (2022) -
Pharmacogenomic Biomarkers in Neuropsychiatry: The Path to Personalized Medicine in Mental Disorders
por: Cacabelos, Ramón
Publicado: (2009) -
Pharmacogenetics of Vascular Risk Factors in Alzheimer’s Disease
por: Cacabelos, Ramón, et al.
Publicado: (2018)